Despite amitriptyline missing the primary endpoint of significantly improving pain relief, disability, and work-related outcomes at 6 months for people with chronic low back pain, shorter term ...

If you're among the one in 10 Americans who regularly suffers from migraines, you'll know that pain relief sometimes isn't enough. In fact, overuse of pain relievers can make symptoms worse. Migraines ...

GLASGOW, United Kingdom ― Amitriptyline, titrated at low dose, was superior to placebo as a second-line treatment for irritable bowel syndrome (IBS) across multiple outcomes in what the researchers ...

Amitriptyline can improve symptoms of irritable bowel syndrome in patients seen in GP surgeries, new research has found. The cheap and widely available prescription drug, which is commonly used at low ...

People who have fibromyalgia hurt all over. And to make matters worse, many of them have been told, "It's all in your head." Marked by chronic, body-wide pain, the disorder may bring with it fatigue, ...

Review the side-effects of Amitriptyline and Perphenazine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.

Please provide your email address to receive an email when new articles are posted on . In a noninferiority randomized trial, venlafaxine reduced the number of ...

We conducted a randomized, double-blind, placebo-controlled trial of amitriptyline (1 mg per kilogram of body weight per day), topiramate (2 mg per kilogram per day), and placebo in children and ...

Countless people in the UK take amitriptyline on prescription to help manage long-lasting nerve pain, depression, or even to prevent migraines. But did you know that the pain-relief drug isn't always ...

Amitriptyline and placebo are equally effective in the management of pain-predominant functional gastrointestinal disorders (FGIDs) in children, according to the results of a new multicenter study ...

A cheap and widely available prescription drug can improve symptoms of irritable bowel syndrome in patients seen in GP surgeries, new research presented today [16 October] at UEG Week 2023 has found.